Reuters: Fenofibrate curbs heart disease in diabetics

[NaDiNe]

Fenofibrate curbs heart disease in diabetics
      
   
      

NEW YORK (Reuters Health) - Treatment with fenofibrate, a cholesterol-lowering drug, reduces the risk of heart disease in patients with type 2 diabetes and components of the metabolic syndrome, researchers report in the journal Diabetes Care.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login